Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy.

[1]  G. Kay,et al.  Design and Implementation of the Dual Site Atrial Pacing to Prevent Atrial Fibrillation (DAPPAF) Clinical Trial , 2004, Journal of Interventional Cardiac Electrophysiology.

[2]  L. Goldman,et al.  Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. , 2002, The New England journal of medicine.

[3]  C. Good,et al.  Amiodarone to prevent recurrence of atrial fibrillation. , 2000, The New England journal of medicine.

[4]  S. Connolly,et al.  Randomized crossover comparison of DDDR versus VDD pacing after atrioventricular junction ablation for prevention of atrial fibrillation. The atrial pacing peri-ablation for paroxysmal atrial fibrillation (PA (3)) study investigators. , 2000, Circulation.

[5]  C. Lau,et al.  Effects of biatrial pacing in prevention of postoperative atrial fibrillation after coronary artery bypass surgery. , 2000, Circulation.

[6]  M. Allessie,et al.  Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol. , 2000, Circulation.

[7]  M Gent,et al.  Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes , 2000 .

[8]  S. Connolly,et al.  Amiodarone to Prevent Recurrence of Atrial Fibrillation , 2000 .

[9]  S. Saksena,et al.  Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single- and dual-site right atrial pacing for arrhythmia prevention. , 1998, Journal of the American College of Cardiology.

[10]  S. Saksena,et al.  Regional right and left atrial activation patterns during single- and dual-site atrial pacing in patients with atrial fibrillation. , 1998, The American journal of cardiology.

[11]  D. Levy,et al.  Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. , 1998, Circulation.

[12]  C. Tai,et al.  Effects of different atrial pacing modes on atrial electrophysiology: implicating the mechanism of biatrial pacing in prevention of atrial fibrillation. , 1997, Circulation.

[13]  L. Thuesen,et al.  Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome , 1997, The Lancet.

[14]  M Hill,et al.  Acute effects of dual-site right atrial pacing in patients with spontaneous and inducible atrial flutter and fibrillation. , 1997, Journal of the American College of Cardiology.

[15]  S. Saksena,et al.  Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing. , 1996, Journal of the American College of Cardiology.

[16]  A. Camm,et al.  A New Pacing Algorithm for Overdrive Suppression of Atrial Fibrillation , 1994, Pacing and clinical electrophysiology : PACE.

[17]  C. Leclercq,et al.  [Permanent atrial resynchronization by synchronous bi-atrial pacing in the preventive treatment of atrial flutter associated with high degree interatrial block]. , 1994, Archives des maladies du coeur et des vaisseaux.

[18]  I. V. Van Gelder,et al.  Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter. , 1989, The American journal of cardiology.

[19]  E. Pritchett,et al.  Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group. , 1989, Circulation.

[20]  B. Hoogwerf,et al.  Conflict-of-interest guidelines for a multicenter clinical trial of treatment after coronary-artery bypass-graft surgery. , 1989, The New England journal of medicine.

[21]  E. Antman,et al.  Long-term oral propafenone therapy for suppression of refractory symptomatic atrial fibrillation and atrial flutter. , 1988, Journal of the American College of Cardiology.